DNM1L and cancer: Since mitochondrial fusion and fission are important for cell function and survival and modulators of mitochondrial division are considered anti-cancer therapeutic agents, we investigated the effects of mitochondrial division inhibitor-1 (mdivi-1), a selective inhibitor to Drp1, on cell death in human renal carcinoma cell line Caki-1.